The National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health (NIH) intends to award a firm-fixed price sole source contract to:
Stemcell Technologies Inc., 12698 Gateway Dr. S, Tukwila, WA 98168
For:
• 130 EasySep Negative Human CD4 Kit catalog#19052 - manufacturer Stemcell Technologies Inc.
• 30 EasySep Negative Human CD8 Kit catalog#19053- manufacturer Stemcell Technologies Inc.
That works exclusively with RoboSep cell separation systems currently in use at the location.
FOB Point shall be Destination; Bethesda, MD 20814.
Place of Performance:
10 Center Drive
Bethesda, MD 20814
The associated North American Industry Classification System (NAICS) code for this procurement is 325414 with a small business size standard of 1250. Stemcell Technologies Inc. is a small business.
This will be the only notice of the Government's intent to solicit, negotiate, and award to one source to satisfy this requirement. The Government plans to award a contract for this requirement within 30 days of this notice.
While this synopsis does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy this requirement. The Government understands that Stemcell Technologies Inc. is the only vendor which can provide the requested items for NIAID. However, firms that believe they can provide the capability required to fully meet the Government's requirement may submit a capability statement, proposal or quotation that will be considered by this Agency in writing to the identified point of contact within ten (10) days after publication of this notice. Such documentation shall be evaluated solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. Interested parties may identify their interest and capability to respond to the requirement or submit offers on NOI-RML-E-1847820.
For additional information or to submit responses, please contact Janna Weber; (E-Mail/ [email protected]).